QTTB(QTTB)
QTTB
ANALYST COVERAGE8 analysts
HOLD
▲ +132.8%upside to target
L $13.00
Med $13.50consensus
H $14.00PRICE
Prev Close
5.50
Open
5.82
Day Range5.61 – 6.14
5.61
6.14
52W Range1.35 – 8.05
1.35
8.05
66% of range
VOLUME & SIZE
Avg Volume
311.7K
FUNDAMENTALS
P/E Ratio
2.2x
Value territory
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
54
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 24
DEx-Dividend
In 90 days
Aug 21
PDividend Pay
In 128 days
Sep 28
QTTB News
About
homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Arthur Tzianabos
Website
Maria MarzilliChief Business Officer
Adrien SiposInterim Chief Medical Officer
Shelia VioletteCo-founder, Chief Scientific Officer & President of Research
David AppuglieseSenior Vice President & Head of People
Lee H. KalowskiChief Financial Officer & President
Jodie Pope MorrisonChief Executive Officer & Director